Atrial natriuretic peptides, B-type natriuretic peptide (BNP), and C-type peptides play important roles in the cardiovascular system (1)(2)(3). ProBNP is a 108-amino acid peptide that is secreted by the ventricle and is cleaved to physiologically active BNP (amino acids 77–108) and N-terminal fragment NT-proBNP (amino acids 1–76) (3). NT-proBNP is a useful marker for heart failure, including congestive heart failure (4)(5)(6). Recently, Roche Diagnostics marketed an automated NT-proBNP assay on the Elecsys analyzer. The assay uses polyclonal antibodies against NT-proBNP. The concentration of NT-proBNP in healthy individuals depends on both age and gender, with females and elderly patients having higher concentrations. The clinical sensitivity and specificity of NT-proBNP at a cutoff of 125 ng/L for male patients younger than 75 years are 81.6–91.7% (sensitivity) and 86.7–95.7% (specificity), depending on age. The corresponding sensitivity and specificity for female patients are 86.7–94.3% (sensitivity) and 57.8–84.9% (specificity), respectively. The negative predictive value of this test is almost 100% at a clinical threshold of 125 ng/L, according to the package insert (NT-proBNP; Roche Diagnostics). A common practice in clinical laboratories is to draw blood in serum-separator tubes because of the advantage of the barrier gel, which facilitates rapid separation of serum from cellular constituents of blood and prevents hemolysis during prolonged storage. However, measured concentrations of certain drugs, such as phenytoin, phenobarbital, carbamazepine, quinidine, and lidocaine, can be reduced if specimens are stored in Becton Dickinson SSTTM tubes (7). Bush et al.(8) reported reductions in estradiol concentrations when specimens were stored in SST tubes. The purpose of the current study was to determine the stability of NT-proBNP in specimens stored in …
Read full abstract